Leif Jörgensen
- Exercise test with dry air inhalation compared to mannitol test as marker of exercise induced asthmaBy Kai-Håkon Carlsen, Leif Bjermer, Barbro Dahlén, Tommy Ekström, Gunilla Hedlin, Trine Stensrud, Leif Jörgensen and Kjell LarssonKai-Håkon CarlsenLeif Bjermer4Dept. of Resiratory Med. & Allergology, Lund University Hospital, Lund, SwedenBarbro Dahlén5Dept. of Medicine, Division of Respiratory Med. and Allergy, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, SwedenTommy Ekström6Astra Zeneca Nordic, Södertälje, SwedenGunilla Hedlin7Dept. of Women's and Children's Health, Centre for Allergy Research, Karolinska Institutet, Stockholm, SwedenTrine Stensrud1Section of Sport Medicine, Norwegian School of Sport Sciences, Oslo, NorwayLeif Jörgensen6Astra Zeneca Nordic, Södertälje, SwedenKjell Larsson8Unit of Lung and Allergy Research, National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- Effect of budesonide/formoterol, budesonide and terbutaline on exercise-induced bronchoconstriction in mild intermittent asthmaBy Nikolaos Lazarinis, Leif Bjermer, Kai-Håkon Carlsen, Barbro Dahlén, Tommy Ekström, Gunilla Hedlin, Leif Jörgensen, Teet Pullerits and Kjell LarssonNikolaos Lazarinis1Department of Medicine, Division of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, SwedenLeif Bjermer2Department of Respiratory Medicine & Allergology, Lund University Hospital, Lund, SwedenKai-Håkon Carlsen3Norwegian School of Sports Sciences, University of Oslo, Oslo University Hospital, Department of Paediatrics, Oslo, NorwayBarbro Dahlén1Department of Medicine, Division of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, SwedenTommy Ekström4Medical, AstraZeneca Nordic, Södertälje, SwedenGunilla Hedlin5Astrid Lindgren's Childrens Hospital, Karolinska University Hospital Solna, Stockholm, SwedenLeif Jörgensen4Medical, AstraZeneca Nordic, Södertälje, SwedenTeet Pullerits6Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Göteborg, SwedenKjell Larsson7Unit of Lung and Allergy Research, National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- Pneumonia in COPD patients treated with fixed ICS/LABA combinationsBy Christer Janson, Kjell Larsson, Karin Lisspers, Björn Ställberg, Georgios Stratelis, Gunilla Telg, Leif Jörgensen and Gunnar JohanssonChrister Janson1Department of Medical Sciences, Respiratory Medicine, Uppsala University, Uppsala, SwedenKjell Larsson2Unit of Lung and Allergy Research, National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenKarin Lisspers3Department of Public Health and Caring Sciences, Family Medicine and Clinical Epidemiology, Uppsala University, Uppsala, SwedenBjörn Ställberg3Department of Public Health and Caring Sciences, Family Medicine and Clinical Epidemiology, Uppsala University, Uppsala, SwedenGeorgios Stratelis4Medical, AstraZeneca Nordic, Södertälje, SwedenGunilla Telg4Medical, AstraZeneca Nordic, Södertälje, SwedenLeif Jörgensen4Medical, AstraZeneca Nordic, Södertälje, SwedenGunnar Johansson5Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden
- COPD in primary care in Sweden - An 11 years epidemiological register studyBy Karin Lisspers, Kjell Larsson, Björn Ställberg, Christer Janson, Gunilla Telg, Leif Jörgensen, Georgios Stratelis and Gunnar JohanssonKarin Lisspers1Department of Public Health and Caring Sciences, Family Medicine and Clinical Epidemiology, Uppsala University, Uppsala, SwedenKjell Larsson2Unit of Lung and Allergy Research, National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenBjörn Ställberg1Department of Public Health and Caring Sciences, Family Medicine and Clinical Epidemiology, Uppsala University, Uppsala, SwedenChrister Janson3Department of Medical Sciences, Respiratory Medicine, Uppsala University, Uppsala, SwedenGunilla Telg4Medical, AstraZeneca Nordic, Södertälje, SwedenLeif Jörgensen4Medical, AstraZeneca Nordic, Södertälje, SwedenGeorgios Stratelis4Medical, AstraZeneca Nordic, Södertälje, SwedenGunnar Johansson1Department of Public Health and Caring Sciences, Family Medicine and Clinical Epidemiology, Uppsala University, Uppsala, Sweden
- Effectiveness of fixed ICS/LABA combinations in COPD - A population based register linkage studyBy Bjorn Stallberg, Christer Janson, Karin Lisspers, Gunnar Johansson, Leif Jörgensen, Georgios Stratelis, Gunilla Telg and Kjell LarssonBjorn Stallberg1Dep. of Public Health and Caring Science, Family Medicine and Clinical Epidemiology, Uppsala University, Uppsala, SwedenChrister Janson2Dep. of Medical Sciences, Respiratory Medicine, Uppsala University, Uppsala, SwedenKarin Lisspers1Dep. of Public Health and Caring Science, Family Medicine and Clinical Epidemiology, Uppsala University, Uppsala, SwedenGunnar Johansson1Dep. of Public Health and Caring Science, Family Medicine and Clinical Epidemiology, Uppsala University, Uppsala, SwedenLeif Jörgensen3Medical, AstraZeneca Nordic, Södertälje, SwedenGeorgios Stratelis3Medical, AstraZeneca Nordic, Södertälje, SwedenGunilla Telg3Medical, AstraZeneca Nordic, Södertälje, SwedenKjell Larsson4Unit of Lung and Allergy Research, National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- Costs and effects of structured COPD care - An observational, matched-cohort studyBy Karin Lisspers, Gunnar Johansson, Christer Jansson, Georgios Stratelis, Leif Jörgensen, Kjell Larsson, Morten Hedegaard and Björn StällbergKarin Lisspers1Department of Public Health and Caring Services, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, SwedenGunnar Johansson1Department of Public Health and Caring Services, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, SwedenChrister Jansson2Department of Medical Sciences, Respiratory Medicine, Uppsala University, Uppsala, SwedenGeorgios Stratelis3R&D, Astrazeneca, Södertälje, SwedenLeif Jörgensen3R&D, Astrazeneca, Södertälje, SwedenKjell Larsson4Unit of Lung and Allergy Research, National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenMorten Hedegaard5Global Commercial, Astrazeneca, Copenhagen, DenmarkBjörn Ställberg1Department of Public Health and Caring Services, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.